Secretariat

c/o Congrès Inc.
5-5-3, Kita 7-jo Nishi Kita-ku,
Sapporo, 060-0807, JAPAN
E-mail:cvit2024@congre.co.jp

Call for Abstracts

Submission Period

November 8(Wed.) ~ January 12th(Fri.)

cnoon on January 22 (Mon.) (JST/GMT+9)

Thank you for your submission! Abstract Submission has closed.

How to Submit Abstracts

All submissions must be made online via this website.

  • This page is for overseas participants only.Participants who live in Japan, including the foreign students, should submit abstracts from the abstract submission page in Japanese .
  • For invited speakers: Organizing Secretariat will contact individually regarding the abstract submission. Please do not submit an abstract through this page.
  • Please submit an abstract from the “Abstract Submission” button at the bottom of this page. You need to create an account first from the “Create Your Account” button. Please secure your ID and password to check or revise your abstract after the submission.
  • Once you have created an account, please submit your abstract from “Abstract Submission (Doctor)” button on your account.
  • Before completing your abstract submission, please make sure to check your abstract in PDF at the preview page. After you make a final check of the abstract, please check the box and click “SUBMIT” button and complete the abstract submission.
  • Confirmation e-mail will be sent after the submission. If you do not receive the e-mail, please contact the organizing secretariat by e-mail (cvit2024-pg@congre.co.jp).

Application Qualification

If author and co-authors for this registration belong to overseas affiliations, they are not required to be a member of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT). However, if the author/co-author belongs to an institution in Japan, membership registration to CVIT by the meeting dates is required.

Presentation Type

01 Oral (English)
02 Poster (English)

Category for Contributed Papers

01 ACS
02 Antiplatelet Therapy
03 Aortic valve intervention (TAVI/Valvuloplasty)
04 Bifurcated Lesion
05 BMS/BRS
06 CABG vs. PCI vs. OMT
07 CKD/HD
08 Closure device (PFO/ASD/LA appendage/PDA)
09 Chronic limb-threatening ischemia (CLTI)
10 Complications
11 COVID-19
12 Congenital Heart Disease
13 CT/MRI/Scintigraphy
14 CTEPH/BPA/PH
15 CTO
16 DCB
17 DES
18 Distal Protection Devices/Thrombectomy
19 Diabetes/Dyslipidemia/HT/Smoking/Other Risk Factors
20 Emergency Care
21 Endovascular Intervention(Carotid/Subclavian/acute stroke)
22 Endovascular Intervention (Thoracic/Abdominal)
23 Endovascular Intervention (Shunt for HD)
24 Endovascular Intervention(Iliac/Femoral/BTK)
25 Epidemiology/Financial cost
26 Flow Wire/Pressure Wire/FFR CT
27 Guiding catheter
28 Heart Failure
29 ICD/CRT/CRTD/Electrophysiology
30 IVUS/OCT/Angioscopy
31 Kawasaki Disease
32 Laser Angioplasty
33 LMT
34 Mechanical circulatory support (IABP/ECMO/Impella)
35 Mitral Valve Intervention
36 Multivessel Disease
37 Pathology
38 Peripheral Artery Disease (PAD)
39 POBA/Cutting Balloon/Scoring Device
40 Prognosis
41 PTSMA
42 Pulmonary Embolism/DVT/Venous disease
43 Radial access/distal radial access/Less invasive strategy  
44 Renal Denervation
45 Restenosis/ISR
46 Rotablator/OAS/DCA/IVL
47 Secondary Prevention/OMT
48 Small Vessel Disease/Diffuse Lesion
49 Stent Thrombosis
50 Thrombolysis
51 Others

Your abstract needs to be

Title of Abstract: Up to 20 words

Body of Abstract: 220 words or less including spaces and punctuations without any image (picture, chart or diagram).
130 words or less including spaces and punctuations with an image (picture, chart or diagram) in your abstract.

Privacy Policy

The CVIT2024 entrusts the collecting, storing, and handling of the personal information provided to us, to MICE one Corporation.

The personal information that you provide through the online submission system, will be used for the following purposes only:

  • to answer your inquiries regarding the meeting.
  • to send you the notification of review results.
  • to post your names, affiliations, presentation titles and abstracts on the official website and publish the program book / meeting APP.

Contact for CVIT Membership

If author and co-authors for this registration belong to overseas affiliations, they are not required to be a member of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT). However, if the author/co-author belongs to an institution in Japan, membership registration to CVIT by the meeting dates is required.

The Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT)

TEL: +81-3-6280-4126
FAX: +81-3-6280-4127
E-mail: info@cvit.jp
CVIT website (Japanese only): http://www.cvit.jp/

Submission system

Abstract Submission

Inquiries for Abstract Submission

If you have any questions about abstract submission, please contact cvit2024-pg@congre.co.jp

Secretariat

c/o Congrès Inc.
5-5-3, Kita 7-jo Nishi Kita-ku,
Sapporo, 060-0807, JAPAN
E-mail:cvit2024@congre.co.jp

Page top